← All indications
Cholangitis, Sclerosing
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
Drugs by status
Phase 4 trials (1)
Phase 3 trials (8)
Phase 2 trials (27)
- cladribine
- thalidomide
- hymecromone
- aramchol
- berberine
- brivanib alaninate
- btt-1023
- aldesleukin
- mitomycin
- Vidofludimus
- Volixibat
- sulfasalazine
- cenicriviroc
- umbilical cord mesenchymal stem cells
- human fecal microbiota
- curcumin
- fenofibrate
- sodium chloride
- tretinoin
- lapachone
- seladelpar
- elafibranor
- sulfated oxysterol
- Bexotegrast
- cm-101
- a3907
- brs201
Phase 1 trials (12)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (20)
- Takeda
- Gilead Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Dr. Falk Pharma GmbH
- Maastricht University
- Arizona State University
- Radboud University
- Stanford University
- University of Groningen
- Utrecht University
- Mayo Clinic
- Leiden University
- Istituto Clinico Humanitas - Rozzano (MI), Italy
- University of Amsterdam
- Medical University of Vienna
- Karolinska Institute
- University of Barcelona
- Ludwig Maximilians University
- Erasmus University Rotterdam
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 2 Indications (28)
- Celgene
- Shire
- Intercept Pharmaceuticals
- Biotie Therapies
- EuroPharma, Inc.
- HighTide Biopharma Pty Ltd
- NGM Biopharmaceuticals, Inc
- Tobira Therapeutics, Inc.
- CymaBay Therapeutics, Inc.
- Durect
- Iltoo Pharma
- National Center for Research Resources (NCRR)
- Harvard University
- Gottfried Wilhelm Leibniz Universität Hannover
- Johns Hopkins University
- University of Florida
- University of Miami
- University of Birmingham
- Yale University
- inVentiv
- Scripps
- University of Paris
- Pliant Therapeutics
- National Institute for Health Research, United Kingdom
- European Union
- People's Liberation Army of China
- Mirum Pharmaceuticals, Inc.
- ChemomAb Ltd.
Organization Involved with Phase 1 Indications (17)
- Genentech
- Aarhus University
- University of Pennsylvania
- University of Arizona
- University of Pittsburgh
- Baylor University
- Emory University
- Northwestern University
- Sacramento Pediatric Gastroenterology
- University of Southern California
- University of Tennessee
- University of California, Davis
- University of California, San Francisco
- University of Colorado, Denver
- Icahn School of Medicine at Mount Sinai
- Nucleus Network Ltd
- PSC Partners Seeking a Cure Foundation
Organization Involved with Other Experimental Indications (3)